27 The study by Ferrannini et al 21 was an exception, in that the mean body weight reductions did not reach statistical significance, although they were higher than with the placebo at all doses.
← all excerpts
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes.
1
—
—